GLIPIZIDE Overview
GLIPIZIDE
- TABLET; ORAL: 5MG; 10MG; 5MG; 10MG; 5MG; 5MG; 10MG; 10MG; 10MG; 10MG; 10MG; 5MG
- TABLET, EXTENDED RELEASE; ORAL: 2.5MG; 5MG
- TABLET; ORAL: 5MG
Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).
| FDA application | Dosage Form | Strength | Marketing Status | Company |
|---|---|---|---|---|
| NDA #074223 | TABLET; ORAL | 5MG | Prescription | WATSON LABS |
| NDA #074226 | TABLET; ORAL | 10MG | Prescription | MYLAN |
| NDA #074305 | TABLET; ORAL | 5MG | Prescription | SANDOZ |
| NDA #074370 | TABLET; ORAL | 10MG | Prescription | WATSON LABS |
| NDA #074378 | TABLET; ORAL | 5MG | Discontinued | ENDO PHARMS |
| NDA #074387 | TABLET; ORAL | 5MG | Prescription | TEVA |
| NDA #074438 | TABLET; ORAL | 10MG | Prescription | ALPHAPHARM |
| NDA #074497 | TABLET; ORAL | 10MG | Prescription | IVAX PHARMS |
| NDA #074542 | TABLET; ORAL | 10MG | Prescription | SANDOZ |
| NDA #074550 | TABLET; ORAL | 10MG | Prescription | KALI LABS |
| NDA #074619 | TABLET; ORAL | 10MG | Prescription | PLIVA |
| NDA #075795 | TABLET; ORAL | 5MG | Prescription | TORPHARM |
| NDA #076467 | TABLET, EXTENDED RELEASE; ORAL | Multiple Strengths | Prescription | WATSON LABS |
| NDA #077820 | TABLET; ORAL | 5MG | Prescription | CARACO |
